REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
23/03/2026
Voltar para busca
Dado oficial do USPTO
NOVOCHIZOL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NOVOCHIZOL
ST13
US500000079289547Classe
1, 3, 5
Pedido
79289547
Registro
6297647
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
24/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 3, 5
Data de depósito
18/12/2019
Data de registro
23/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/03/2021
Última transação
24/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
CH
Examinador
JENKINS, KEISHA MONIQUE HARD
Unidade examinadora
M30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Novochizol SA
BOSTI Trading Ltd.
Representantes
Brian Tamsut SoCal IP Law Group LLP
Classificação técnica
Classes Nice
Classe 1Classe 3Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical coating agents for medical devices; flocculants; chemicals for use in the purification of water; chemicals for use in separation and purification techniques; chemicals for use in chromatography; biochemical catalysts; tensio-active chemical agents and surface-active chemical agents for formulating poorly water-soluble substances; solubilizing agent for aerosols; chitosan for use as a raw ingredient in the manufacture of cosmetics or pharmaceuticals; preservatives for use in the pharmaceutical industry; chitosan-based polymers for use in the manufacture of pharmaceutical and cosmetic preparations; solubilizing agent for aerosol pharmaceutical preparations
Classe 3
Non-medicated gelscreams and lotions for use against wrinkles and signs of aging; topical skin sprays for cosmetic purposes; cosmetic preparations for skin care; biopolymer-based non-medicated cosmetics and non-medicated toiletry preparations; biopolymer-based cosmeticsin particular non-medicated gelscreams and lotionsfor use against wrinkles and signs of aging; biopolymer-based topical skin sprays for cosmetic purposes; biopolymer-based cosmetic preparations for skin care
Classe 5
Pharmaceutical and veterinary preparations for tissue repairjoint treatment and drug delivery; Pharmaceutical substances and preparations for healthcarefor tissue repairjoint treatment and drug delivery; pharmaceutical preparations for the treatment of eye diseases and conditions; eye drops; Medicated eye washcollyria; anti-infective preparations for veterinary purposes; biological implantsa vital processed human or animal connective tissue; surgical implants comprised of living tissues; biological tissue cultures for medical use; anti-protozoan agents; anti-inflammatory agents; drug delivery agentsdrug delivery agents in the form of powders or suspensions that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic reagents and contrast media for medical purposes and use with imaging medical equipmentnamely X-ray tomographyNMR tomographyultrasound tomographyopticalluminescence and fluorescence tomographyEPR tomography and Terahertz tomography; Bandage material for dressings; Bandage material for hemostatic dressings; surgical and medical dressings; pre-filled syringes filled with medicinal products or fillers for medical purposes; injectable soft-tissue dermal fillersintra-articular fillers and intra-vascular fillers; bone void fillersintra-articular fillers and intra-vascular fillers comprised of living tissues; topical first aid gels for medical and therapeutic use
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/07/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/07/2021
FIMP
FINAL DISPOSITION PROCESSED
01/07/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/06/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
04/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
23/03/2021
GPNX
NOTIFICATION PROCESSED BY IB
11/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/01/2021
PUBO
PUBLISHED FOR OPPOSITION
05/01/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/12/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/11/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/11/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/11/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/11/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/11/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/11/2020
RFNT
REFUSAL PROCESSED BY IB
30/08/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/08/2020
RFRR
REFUSAL PROCESSED BY MPU
11/08/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/07/2020
CNRT
NON-FINAL ACTION WRITTEN
28/07/2020
MAFR
APPLICATION FILING RECEIPT MAILED
28/07/2020
DOCK
ASSIGNED TO EXAMINER
23/07/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/07/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
21/07/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/07/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NOVOCHIZOL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.